• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Ferring`s Bio-tropin (Somatropin ) Receives Suppl Approvals in the U.S

    FDA

    Ferring`s Zomacton (Somatropin) Receives Suppl Approvals in the U.S

    FDA

    Eli Lilly`s Biologic Humatrope (somatropin) Receives Approval in the U.S.

    FDA

    Sandoz`s Biologic Omnitrope (Somatropin) Receives Approval in the U.S.

    FDA

    Ascendis Pharma Bags EU Approval for TransCon hGH for Pediatric hGH Deficiency

    GLOBENEWSWIRE

    I-Mab Receives China CDE Approval to Initiate Ph 3 Trial of Eftansomatropin

    PRNASIA

    Ascendis Announces Filing of the Clinical Trial Notification for TransCon™

    SEEKING ALPHA

    OPKO Health and Pfizer report positive Phase III data for somatrogon

    CLINICALTRIALSARENA

    OPKO, Pfizer announce positive results from ph3 trial of somatrogon

    PHARMABIZ

    FDA Compiles List of NDAs Transitioning to BLAs Next March

    RAPS

    Guideline on biosimilars containing biotech-derived proteins as Active Substance

    EMA

    Government restores customs duty exemption on three drugs

    ECONOMIC TIMES

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.